Executive-only • Curated admission • Limited seats | Dates: 19–21 May 2027 | Venue: Vienna, Austria
Executive cadence • Clinical translation • Evidence to impact • Outcome-led collaboration

Official Agenda 12th European Executive Congress on Clinical & Translational Medicine

The EECCTM 2027 agenda has been structured as a focused three-day executive program for senior leaders working across clinical development, translational science, healthcare innovation, implementation, and strategic partnerships. The congress is designed to move from discussion to decision-making, with dedicated time for curated introductions, closed-door sessions, evidence-led exchange, and follow-up planning.

Congress overview

A premium executive format built for high-trust dialogue, practical exchange, strategic introductions, and measurable next steps.

Seats limited
Dates
19–21 May 2027
Location
Vienna, Austria
See venue details
Participation model
Apply → Confirm → Register
Relevance-first access and verified executive attendance
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Format
Executive-only

Participation is curated to protect relevance, trust, and quality of discussion.

Program arc
3-day structure

Day 1 aligns priorities, Day 2 deepens the discussion, Day 3 converts dialogue into actions and pathways.

Core focus
Evidence to impact

Clinical strategy, translational design, implementation planning, and partnership-led progress.

Designed outcome
Next steps

Focused follow-ups, strategic introductions, practical collaboration pathways, and post-event continuity.

Day 1 • Wednesday, 19 May 2027

Executive Alignment, Translational Priorities & Curated Introductions

The opening day is designed to set the tone of the congress: executive check-in, strategic framing, focused roundtables, and structured introductions aligned to scientific, clinical, and partnership objectives.

Foundation day
08:30–09:30
Registration, Arrival Coffee & Executive Orientation

Delegate arrival, welcome support, orientation to the participation model, and a concise overview of the congress flow, meeting etiquette, and access pathways for closed-door sessions.

09:30–10:00
Opening Address & Congress Positioning

A formal opening to frame the congress objectives across clinical translation, evidence quality, delivery pathways, and collaboration outcomes relevant to executive participants.

10:00–11:15
Executive Roundtable I: Translational Strategy from Discovery to Clinical Relevance

Discussion block focused on translational planning priorities, target-to-patient thinking, evidence expectations, study-readiness considerations, and barriers that delay real-world progression.

11:15–11:45
Executive Coffee & Curated Introduction Window

Moderated networking designed to connect delegates by therapeutic area, technology focus, translational challenge, investment interest, or institutional collaboration needs.

11:45–13:00
Executive Roundtable II: Clinical Evidence, Validation Pathways & Decision Confidence

A focused exchange on evidence thresholds, translational validation, patient relevance, proof strategy, feasibility considerations, and cross-functional decision-making before scale-up or implementation.

13:00–14:00
Networking Lunch

Structured lunch seating built to encourage meaningful introductions among clinical leaders, translational teams, innovation stakeholders, academic partners, and healthcare decision-makers.

14:00–15:15
Session Block: Implementation Readiness in Clinical & Translational Medicine

This block explores how innovation moves beyond scientific promise into operational reality, including delivery models, adoption barriers, interdisciplinary coordination, and implementation planning.

15:15–15:45
Refreshment Break & Bilateral Meeting Window

A lighter session window reserved for pre-arranged introductions, small-group executive conversations, and follow-up discussions based on the day’s earlier roundtables.

15:45–17:00
Strategic Working Session: Priority Mapping, Collaboration Signals & Shared Challenges

Participants consolidate early themes, identify areas of mutual interest, and surface high-priority challenges where future collaboration, pilot planning, or deeper dialogue may be relevant.

18:30–20:00
Invitation-Based Executive Reception

An evening reception designed for relationship-building in a premium setting, allowing senior participants to continue discussions initiated during the daytime agenda.

Day 2 • Thursday, 20 May 2027

Evidence, Decision Frameworks, Implementation Pathways & Strategic Exchange

Day two is the core content day of the congress, bringing together deeper executive discussions on clinical evidence, translational risk, implementation strategy, partnership models, and practical pathways toward impact.

Core congress day
09:00–09:30
Day Briefing & Executive Context Setting

Morning framing of the day’s priorities, including the role of evidence quality, implementation thinking, and executive decision points in moving translational progress forward.

09:30–10:45
Featured Executive Session: Clinical Translation in an Outcomes-Oriented Environment

A high-level content block focused on how organisations are approaching evidence maturity, translational prioritisation, and impact-driven decision-making across clinical and translational medicine.

10:45–11:15
Coffee Break & Delegation Networking

Open networking time for executive peer exchange, partner exploration, and continuation of targeted conversations arising from the morning session.

11:15–12:30
Strategic Panel: Evidence Generation, Translation Risk & Organisational Readiness

Executive perspectives on designing with end-use in mind, balancing innovation with feasibility, strengthening confidence in translational choices, and improving alignment between science, care delivery, and operational execution.

12:30–13:30
Networking Lunch & Executive Table Discussions

Lunch discussions arranged around themes such as clinical delivery, translational design, healthcare partnerships, implementation pathways, and strategic growth opportunities.

13:30–14:45
Focused Session Block: Implementation, Adoption & Real-World Operationalisation

A practical discussion period focused on adoption readiness, health-system alignment, translational bottlenecks, delivery capability, and what is required to move from promising evidence to practical use.

14:45–15:15
Refreshment Break & Partner Meeting Window

Time allocated for one-to-one conversations, relationship development, and targeted introductions based on current priorities and identified areas of alignment.

15:15–16:30
Executive Exchange: Partnership Models, Collaboration Design & Growth Opportunities

A strategic exchange around how clinical, translational, academic, and industry stakeholders can structure meaningful collaboration with a clearer view of goals, capabilities, and next-step opportunities.

16:30–17:15
Congress Synthesis Session: Key Insights, Shared Priorities & Emerging Follow-Ups

This session consolidates major takeaways from the day and highlights emerging partnership interests, unresolved barriers, and areas requiring deeper post-congress engagement.

18:30–20:30
Executive Dinner (Limited Participation)

An optional evening setting for high-level discussion, relationship strengthening, and more focused conversation among selected participants and invited stakeholders.

Day 3 • Friday, 21 May 2027

Partnership Pathways, Executive Follow-Up & Outcome Consolidation

The closing day focuses on continuity. It is designed to convert discussion into defined next steps through synthesis, bilateral opportunity mapping, and practical follow-up planning.

Outcome day
09:00–09:30
Morning Overview & Closing-Day Priorities

A concise start to the final day, focused on outcome orientation, action planning, and the most relevant opportunities for continuing conversations beyond the congress.

09:30–10:45
Synthesis Workshop: What Matters Most After the Congress

Delegates revisit the most relevant themes from the congress and identify which conversations, issues, or opportunities should progress into bilateral follow-up, pilot exploration, or strategic dialogue.

10:45–11:15
Coffee Break & Priority Meeting Coordination

A dedicated coordination window for confirming the most relevant follow-up discussions, reconnecting with selected participants, and clarifying continuation pathways.

11:15–12:30
Partnership Pathways Session: Bilateral Opportunities, Collaboration Formats & Follow-Up Intent

Focused discussion on how executive connections made during the congress can continue beyond the event through practical dialogue, partnership exploration, aligned objectives, and shared next-step structures.

12:30–13:30
Closing Lunch

A final congress lunch for confirming introductions, reinforcing relationships, and enabling last-stage executive conversations before departures begin.

13:30–14:30
Outcome Review: Priority Areas, Shared Signals & Continuity Planning

A structured review of the most relevant themes, recurring executive priorities, collaboration directions, and intended areas for follow-up communication after the congress.

14:30–15:00
Closing Remarks

Official close of the congress, appreciation to participants, and confirmation that relevant post-event communication and coordination will continue through the organising team.